Nearly all ChRCC showed almost total loss of HNF1β as a pathognomonic sign (Figure 6E1,E3) in spite of partial loss (Figure 6E2) as opposed to RO, which showed a totally positive reaction (Figure 6E4). This evidence concerns the gene HNF1B and chromophobe renal cell carcinoma.